Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elena N. Chernikova"'
Autor:
Elena P. Ulianova, Angelina V. Busarova, Natalya V. Porkhanova, Aleksandr B. Sagakyants, Natalia A. Petrusenko, Oksana G. Shulgina, Elena N. Chernikova, Svetlana M. Bakulina, Tatiana F. Pushkareva, Ekaterina V. Verenikina
Publikováno v:
Journal of Clinical Oncology. 40:e17532-e17532
e17532 Background: Vulvar cancer is a rare gynecologic tumor accounting for 2–5% of all gynecologic cancers. The epithelial-mesenchymal transition (EMT) is considered one of the factors contributing to the aggressive behavior of vulvar squamous cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cd1585170b9e38ac05b83db14cda500
https://doi.org/10.1200/jco.2022.40.16_suppl.e17532
https://doi.org/10.1200/jco.2022.40.16_suppl.e17532
Autor:
Elena P. Ulianova, Inna Arnoldovna Novikova, Elena N. Chernikova, Evgeniya M. Nepomnyashchaya, Tatiana F. Pushkareva, Elena A. Dzhenkova, Svetlana M. Bakulina, Aleksandr V. Shaposhnikov, Evgeniy N. Kolesnikov, Aleksandr B. Sagakyants
Publikováno v:
Journal of Clinical Oncology. 39:e16028-e16028
e16028 Background: Over the past 10 years, gastric cancer has been in the top five most common malignant tumors with a high mortality rate. Its poor prognosis is determined by the aggressive disease course with the development of distant metastases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf622d2bc11349bcdf76e2f568382fbc
https://doi.org/10.1200/jco.2021.39.15_suppl.e16028
https://doi.org/10.1200/jco.2021.39.15_suppl.e16028
Autor:
Oleg I. Kit, Vasilij V. Tokmakov, Aleksandr B. Sagakyants, Anna S. Goncharova, Ekaterina V. Zaikina, Svetlana M. Bakulina, Tatiana F. Pushkareva, Elena P. Ulianova, Iuliana S. Shatova, Elena N. Chernikova, Aleksandr E. Lisutin
Publikováno v:
Journal of Clinical Oncology. 38:e12558-e12558
e12558 Background: Breast cancer (BC) is associated with miRNAs, the qualitative and quantitative analysis of which shows significant differences between molecular subtypes, as well as between miRNAs circulating in the bloodstream and detected in tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::febf5e21e6eb4160469aaf5f7c92477b
https://doi.org/10.1200/jco.2020.38.15_suppl.e12558
https://doi.org/10.1200/jco.2020.38.15_suppl.e12558
Autor:
Aleksandr B. Sagakyants, E. P. Lysenko, Svetlana M. Bakulina, Liubov Yu Vladimirova, Vasilij V. Tokmakov, Elena S. Bondarenko, Oksana G. Shulgina, Elena P. Ulianova, Oleg I. Kit, Iuliana S. Shatova, Inna Arnoldovna Novikova, Elena N. Chernikova, Evgeniya M. Nepomnyashchaya
Publikováno v:
Journal of Clinical Oncology. 37:e12065-e12065
e12065 Background: Assessment of proliferative activity is important in terms of tumor prognosis. Topoisomerase IIα (TopIIα) and ki-67 are common markers of breast cancer (BC) cell proliferation. The purpose of the study was to assess the correlati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::052455ad8f945dbf24b9a70615c11f0c
https://doi.org/10.1200/jco.2019.37.15_suppl.e12065
https://doi.org/10.1200/jco.2019.37.15_suppl.e12065
Autor:
Andrey Vladimirovich Bakhtin, Elena P. Ulianova, Dmitry Aleksandrovich Shvyrev, Rukiyat Isaeva, Aleksey Yurievich Maksimov, Inna Arnoldovna Novikova, Elena N. Chernikova, Olesya N. Selyutina, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 33:e22017-e22017
e22017 Background: The purpose of this study was to analyze the content and detection rate of CTCs in blood of patients with kidney, prostate, breast, lung and colon cancers. Methods: 187 patients ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c27a1d7f4a4a30e55c52ba8b480aa81
https://doi.org/10.1200/jco.2015.33.15_suppl.e22017
https://doi.org/10.1200/jco.2015.33.15_suppl.e22017
Autor:
Andrey Vladimirovich Bakhtin, Inna Arnoldovna Novikova, Vera Gabaraeva, Elena N. Chernikova, Yuliana Sergeyevna Shatova, Elena Alekseevna Nikipelova, Elizaveta A. Komova, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 33:e22016-e22016
e22016 Background: The purpose of the study was to assessprobability of detecting CTCs in breast cancer without distant metastases. Methods: 25 stage IIa-IIIa stage breast cancer patients were recr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57c40ace93043a4ce11088ad84d439b3
https://doi.org/10.1200/jco.2015.33.15_suppl.e22016
https://doi.org/10.1200/jco.2015.33.15_suppl.e22016